Data as of Sep 19
| -0.64 / -2.05%|
The 11 analysts offering 12-month price forecasts for Imperva Inc have a median target of 35.00, with a high estimate of 42.00 and a low estimate of 25.00. The median estimate represents a +14.49% increase from the last price of 30.57.
The current consensus among 13 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.